References
1. Belyaeva E.V., Lapshina L.V., Shaposhnikova E.V., Belyaeva M.V. Experience of managing pregnant women with nervous system pathology in a day hospital of the consultative and diagnostic department. Lechashchiy vrach [Attending Physician]. 2019; (3): 56–9. (in Russian)
2. Jain R., Rathi P.S., Telang K., Zaidi A. A case of Guillain-Barre syndrome with pregnancy who delivered in ICU: a rare outcome of rare co-occurrence. BMJ Case Rep. 2019; 12 (11): e230650. DOI: https://doi.org/10.1136/bcr-2019-230650
3. Piradov M.A., Suponeva N.A., Shnayder N.A., Spirin N.N., Grishina D.A., Sergeev D.V., et al. Guillain–Barre syndrome. Federal Clinical Guidelines. Moscow: 2019: 18 p. (in Russian)
4. Jasti A.K., Selmi C., Sarmiento-Monroy J.C., Vega D.A., Anaya J.M., Gershwin M.E. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol. 2016; 12 (11): 1175–89. DOI: https://doi.org/10.1080/1744666X.2016.1193006
5. Madden J., Spadaro A., Koyfman A., Long B. High risk and low prevalence diseases: Guillain-Barré syndrome. Am J Emerg Med. 2024; 75: 90–7.
6. Myers T.R., McCarthy N.L., Panagiotakopoulos L., Omer S.B. Estimation of the incidence of Guillain-Barré syndrome during pregnancy in the United States. Open Forum Infect Dis. 2019; 15 (6): ofz071. DOI: https://doi.org/10.1093/ofid/ofz071
7. Krief N., Gabriel R., Cauquil C., et al. Clinical features and maternal and fetal outcomes in women with Guillain-Barré syndrome in pregnancy. J Neurol. 2023; 270 (9): 4498–506. DOI: https://doi.org/10.1007/s00415-023-11808-w
8. Stoian A., Motataianu A., Bajko Z., Balasa A. Guillain-Barré and acute transverse myelitis overlap syndrome following obstetric surgery. J Crit Care Med (Targu Mures). 2020; 6 (1): 74–9. DOI: https://doi.org/10.2478/jccm-2020-0008
9. Peganova M.A., Filimonov S.N., Peganov A.I., et al. Clinical case of Guillain–Barre syndrome on the background of eclampsia in a pregnant woman. Meditsina v Kuzbasse [Medicine in Kuzbass]. 2020; 19 (2): 48–51. (in Russian)
10. Sattarova S.Z., Azizova R.B., Abdullaeva N.N., Samieva G.U. Clinical features, course and diagnosis of Guillain–Barré syndrome Zhurnal biomeditsiny i praktiki [Journal of Biomedicine and Practice]. 2021; Vol. 6 (1): 69–77. (in Russian)
11. McGrogan А., Madle G.C., Seaman H.E., Vries C.S. de. The Epidemiology of Guillain-Barre syndrome worldwide a systematic literature review. Neuroepidemiology. 2009; 32: 150–63.
12. Affes L., Elleuch M., Mnif F., et al. Syndrome de Guillain Barré et décompensation acidocétosique du diabète au cours de la grossesse: a propos d’un cas et revue de la littérature. Pan Afr Med J. 2017; 21 (26): 86. DOI: https://doi.org/10.11604/pamj.2017.26.86.11091 (in French)
13. Wang J., Bahabri A., Wong P., Anantharachagan A. An atypical presentation of pre-eclampsia (PET) in a patient diagnosed with Guillain-Barré syndrome: a case report. Case Rep Womens Health. 2023; 37: e00489. DOI: https://doi.org/10.1016/j.crwh.2023.e00489
14. Raevskaya A.I., Shevchenko P.P., Karpov S.M. Modern methods of diagnostics and treatment of Guillain-Barré syndrome Vestnik molodogo uchenogo [Bulletin of Young Scientist]. 2019; 8 (4): 136–41. (in Russian)
15. Haymaker W.E., Kernohan J.W. The Landry-Guillain-Barré syndrome; a clinicopathologic report of 50 fatal cases and a critique of the literature. Medicine (Baltimore). 1949; 28: 59–141.
16. Feasby T.E., Gilbert J.J., Brown W.F., et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain. 1986; 109: 1115–26.
17. Asbury A.K., Arnason B.G., Adams R.D. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore). 1969; 48: 173–215.
18. Hafer-Macko C., Hsieh S.T., Li C.Y., et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol. 1996; 40: 635–44.
19. Gilbert M., Karwaski M-F., Bernatchez S., et al. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 2002; 277: 327–37.
20. Saariaho A.-H., Vuorela A., Freitag T.L., et al. Autoantibodies against 670 ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus. J Autoimmun. 2015; 63: 68–75.
21. Li S., Jin T., Zhang H.-L., et al. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Mediators Inflamm. 2014; 14: 740947.
22. Kaida K., Morita D., Kanzaki M., et al. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol. 2004; 56: 567–71.
23. Smith D.W., Mackenzie J. Zika virus and Guillain-Barré syndrome: another viral cause to add to the list. Lancet. 2016; 387: 1486–8.
24. Ayres C.F.J. Identification of Zika virus vectors and implications for control. Lancet Infect Dis. 2016; 16. P. 278–279.
25. Laman J.D., Huizinga R., Boons G.J., Jacobs B.C. Guillain-Barré syndrome: expanding the concept of molecular mimicry. Trends Immunol. 2022; 43: 296–308. DOI: https://doi.org/10.1016/j.it.2022.02.003
26. Israeli E., Agmon-Levin N., Blank M., et al. Guillain-Barre syndrome – a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol. 2012; 42: 121–30.
27. Garcia J.J., Turalde C.W., Bagnas M.A., Anlacan V.M. Intravenous immunoglobulin in COVID-19 associated Guillain-Barré syndrome in pregnancy. BMJ Case Rep. 2021; 14 (5): 1–3.
28. Uncini A., Vallat J.M., Jacobs B.C. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J Neurol Neurosurg Psychiatry. 2020; 91: 1105–10.
29. Zubair A.S., Bae J.Y., Desai K. Facial diplegia variant of Guillain-Barré syndrome in pregnancy following COVID-19 vaccination: a case report. Cureus. 2022; 14 (2): e22341. DOI: https://doi.org/10.7759/cureus.22341
30. Finsterer J., Matovu D., Scorza F.A. SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barré syndrome. Clinics (Sao Paulo). 2022; 77: 100064. DOI: https://doi.org/10.1016/j.clinsp.2022.100064
31. Sharma S. Guillain-Barré syndrome during post-partum period: a rare entity. J Neurol Nuerosci. 2021; 12: 389.
32. Leonhard S.E., Mandarakas M.R., Gondim F.A.A., et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019; 15 (11): 671–83. DOI: https://doi.org/10.1038/s41582-019-0250-9
33. Querol L., Lleixà C. Novel immunological and therapeutic insights in Guillain-Barré syndrome and CIDP. Neurotherapeutics. 2021; 18 (4): 2222–35. DOI: https://doi.org/10.1007/s13311-021-01117-3
34. Fokke C., van den Berg B., Drenthen J., et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014; 137: 33–43.
35. Tham S.L., Prasad K., Umapathi T. Guillain-Barré syndrome mimics. Brain Behav. 2018; 10 (5): e00960. DOI: https://doi.org/10.1002/brb3.960